Pharsight

Drug patents revoked in 2018

Drug patents revoked in 2018 at the European Patent Office (EPO).

Patent Number Patent Title Company Revoked Date Oppositions
EP2181696B1 Anti-spot skin treatment HENKEL AG AND CO KGAA Dec, 2018
(Expiration: Oct, 2029)
BEIERSDORF
LOREAL DIPI
EP2499914B1 Antiseptic solutions comprising di-(4-chlorophenyldiguanidino)-hexane and an anionic dye and their preparation MEDICHEM SA Nov, 2018
(Expiration: Mar, 2032)
LAIR LIQUIDE
EP2637664B1 Compositions and methods of treating pulmonary hypertension GILEAD SCIENCES INC Nov, 2018
(Expiration: Oct, 2031)
ALFRED E TIEFENBACHER
GENERICS UK
SANDOZ
STADA ARZNEIMITTEL
TEVA PHARMACEUTICAL INDUSTRIES
ZENTIVA GROUP
EP2484696B1 Antagonistic hLIGHT-specific human monoclonal antibodies KYOWA HAKKO KIRIN CO LTD Nov, 2018
(Expiration: Aug, 2027)
EUROPEAN OPPOSITIONS
EP2519231B1 Proteasome inhibitors for treating cancer JANSSEN PHARMACEUTICA NV Oct, 2018
(Expiration: Oct, 2030)
ACCORD HEALTHCARE
EP2575803B1 Methods of treating bladder cancer ABRAXIS BIOSCIENCE LLC Sep, 2018
(Expiration: May, 2031)
GENERICS UK
EP2783686B1 Combination of a rapamycin derivative and letrozole for treating breast cancer NOVARTIS AG Aug, 2018
(Expiration: Feb, 2022)
GENERICS UK
EP2223687B1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of using and compositions thereof CELGENE CORP Aug, 2018
(Expiration: Mar, 2023)
ZAKLADY FARMACEUTYCZNE POLPHARMA
EP1742958B1 Methods and compositions for the specific inhibition of gene expression by double-stranded rna INTEGRATED DNA TECHNOLOGIES INC Aug, 2018
(Expiration: Mar, 2025)
WUESTHOFF & WUESTHOFF PATENTANWLTE PARTG MBB
EP2957278B1 A stable composition comprising pthrp and uses thereof IPSEN PHARMA SAS Jul, 2018
(Expiration: Oct, 2027)
ISENBRUCK BSL HRSCHLER
TEVA PHARMACEUTICAL INDUSTRIES
EP2338571B1 Agent for colouring and/or bleaching keratinous fibres in two parts, including a particular fatty body and a reductone LOREAL SA Jul, 2018
(Expiration: Dec, 2030)
HENKEL
EP2448548B1 Method for improving the appearance of hyperpigmented spot(s) using an extract of laminaria saccharina PROCTER AND GAMBLE CO May, 2018
(Expiration: Jul, 2030)
UNILEVER